JP Patent

JP6618736B2 — ミラベグロン含有錠剤、ミラベグロン含有製剤の製造方法及びミラベグロン含有造粒物の製造方法

Assigned to Sawai Pharmaceutical Co Ltd · Expires 2019-12-11 · 6y expired

What this patent protects

Patent listed against Myrbetriq.

Drugs covered by this patent

Patent Metadata

Patent number
JP6618736B2
Jurisdiction
JP
Classification
—
Expires
2019-12-11
Drug substance claim
No
Drug product claim
No
Assignee
Sawai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.